Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways

…, M Mlodzik, B Polok, W Driever, T Obara, G Walz - Nature …, 2005 - nature.com
Cystic renal diseases are caused by mutations of proteins that share a unique subcellular
localization: the primary cilium of tubular epithelial cells 1 . Mutations of the ciliary protein …

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

…, A Kramer-Zucker, G Walz… - Proceedings of the …, 2006 - National Acad Sciences
Autosomal-dominant polycystic kidney disease (ADPKD) is a common genetic disorder that
frequently leads to renal failure. Mutations in polycystin-1 (PC1) underlie most cases of …

Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination

…, MF Gagnadoux, H Nivet, C Antignac, G Walz… - Nature …, 2003 - nature.com
Nephronophthisis (NPHP), an autosomal recessive cystic kidney disease, leads to chronic
renal failure in children. The genes mutated in NPHP1 and NPHP4 have been identified, and …

[HTML][HTML] Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice

…, N Mizushima, AS Shaw, G Walz… - The Journal of …, 2010 - Am Soc Clin Investig
Injury and loss of podocytes are leading factors of glomerular disease and renal failure. The
postmitotic podocyte is the primary glomerular target for toxic, immune, metabolic, and …

Recognition by Elam-1 of the Sialyl-Lex Determinant on Myeloid and Tumor Cells

G Walz, A Aruffo, W Kolanus, M Bevilacqua, B Seed - Science, 1990 - science.org
Endothelial leukocyte adhesion molecule-1 (ELAM-1) is an endothelial cell adhesion
molecule that allows myeloid cells to attach to the walls of blood vessels adjacent to sites of …

Autosomal dominant polycystic kidney disease: the changing face of clinical management

ACM Ong, O Devuyst, B Knebelmann, G Walz - The Lancet, 2015 - thelancet.com
Autosomal dominant polycystic kidney disease is the most common inherited kidney disease
and accounts for 7–10% of all patients on renal replacement therapy worldwide. Although …

Wnt signaling in polycystic kidney disease

T Benzing, M Simons, G Walz - Journal of the American Society of …, 2007 - journals.lww.com
Wnt signaling cascades activate morphogenetic programs that range from cell migration and
proliferation to cell fate determination and stem cell renewal. These pathways enable cells …

[HTML][HTML] Role of mTOR in podocyte function and diabetic nephropathy in humans and mice

…, MN Hall, MA Rüegg, K Inoki, G Walz… - The Journal of …, 2011 - Am Soc Clin Investig
Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity,
represent a major health issue. However, they remain poorly understood. Here we have …

[HTML][HTML] mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression

TB Huber, G Walz, EW Kuehn - Kidney international, 2011 - Elsevier
The immunosuppressive drug rapamycin has helped to identify a large signaling network
around the target of rapamycin (TOR) protein that integrates information on nutrient availability …

Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling

…, H Pavenstädt, AS Shaw, G Walz… - … and cellular biology, 2003 - Am Soc Microbiol
Mutations of NPHS1 or NPHS2, the genes encoding nephrin and podocin, as well as the
targeted disruption of CD2-associated protein (CD2AP), lead to heavy proteinuria, suggesting …